Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 16, 2021updated 02 Nov 2021 7:23am

FDA clears Olympus’ NBI to characterise colorectal polyps potential

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Olympus’ Narrow Band Imaging (NBI) to assess the neoplastic potential of colorectal polyps.

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Olympus’ Narrow Band Imaging (NBI) to assess the neoplastic potential of colorectal polyps.

NBI is an optical imaging technology that improves the visibility of vessels and surface patterns on the mucosa.

Physicians can make high-confidence predictions of histology for polyps 5mm or smaller, called diminutive polyps, by applying the NBI International Colorectal Endoscopic (NICE) classification during a screening colonoscopy.

Olympus America Endoscopy vice-president Kevin Mancini said: “We are excited about these newly cleared indications for using NBI to support colorectal cancer screening.

“NBI is an important tool, available as standard on all Olympus colonoscopes, which can be used by physicians to assist in decision making with the goal of improving patient care.”

In support of the clearance, the company submitted data that included a meta-analysis of prospective real-time clinical studies of NBI use at the time of colonoscopy.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

The data showed endoscopists using the NICE classification demonstrated 93% sensitivity, 85% specificity and more than 90% negative predictive value in predicting adenomatous histology of diminutive polyps during colonoscopy with high confidence.

Additionally, they have achieved more than 90% agreement with pathological analysis in assigning post-polypectomy patient surveillance intervals after colonoscopy.

In a randomised clinical trial, endoscopists using near focus mode colonoscopes were more likely to make high confidence predictions of diminutive polyp histology than those using the standard focus colonoscopies.

Olympus noted that at the time of colonoscopy, polyps are usually detected and removed and sent out for pathological diagnosis.

NBI, which can filter out all but blue and green lights absorbed by haemoglobin, also has clinical applications in urology, pulmonology and rhinolaryngology.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU